• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION INTELLAMAP ORION HIGH RESOLUTION MAPPING CATHETER; CATHETER, ELECTRODE RECORDING, OR PROBE, ELECTRODE RECORDING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION INTELLAMAP ORION HIGH RESOLUTION MAPPING CATHETER; CATHETER, ELECTRODE RECORDING, OR PROBE, ELECTRODE RECORDING Back to Search Results
Model Number 87035
Device Problems Difficult to Remove (1528); Device-Device Incompatibility (2919)
Patient Problems Tissue Damage (2104); Device Embedded In Tissue or Plaque (3165)
Event Date 08/20/2020
Event Type  Injury  
Manufacturer Narrative
It was indicated that the device will not be returned for evaluation.If there is any further relevant information obtained, a supplemental medwatch will be filed.
 
Event Description
It was reported that a intellamap orion high resolution mapping catheter was used in a atrial fibrillation procedure.While navigating the left atrium it was noted that the physician was unable to withdraw the orion from the patient.The physician called in a vascular surgeon for help.After trouble shooting it was decided to cut the tip off of the catheter and to leave it inside the patient.The procedure was completed with the tip remaining in the patient was kept under surveillance and on anti-coagulant.
 
Event Description
It was reported that a intellamap orion high resolution mapping catheter was used in a atrial fibrillation procedure.However while navigating the left atrium it was noted that the physician was unable to withdraw the orion from the patient.The physician called in a vascular surgeon for help.After trouble shooting it was decided to cut the tip off of the catheter and to leave it inside the patient.The procedure was completed with the tip remaining in the patient was kept under surveillance and on anti-coagulant.It was further reported via gfe that the catheter was disposed.Literature article was received.It was further reported that a patient with ischemic cardiomyopathy and severe left ventricular dysfunction was referred for catheter ablation of a symptomatic atypical atrial flutter.Preprocedural computed tomography was performed to appreciate atrial anatomy, and rule-out intra-atrial thrombus.Catheter ablation was performed under mild sedation, uninterrupted direct oral anticoagulant and three right femoral venous sheaths.A decapolar diagnostic catheter was positioned in the coronary sinus, with a distal coronary sinus primo-activation pattern.Left atrium (la) activation mapping was performed using a sensor-based 64-electrode basket catheter (intellamap oriontm, boston scientific, usa) through a trans-septal puncture in combination with a long sheath.Activation mapping found a septal anterior primo-depolarization.The la sheath was left in place and right atrial activation mapping was attempted by introducing the basket catheter in a short 8.5fr sheath.During initial progression from the right femoral vein, the basket catheter was trapped at the ostium of the right internal iliac vein.Ipsilateral upward or downward traction/rotation were performed using an non-boston scientific endovascular snare system, unsuccessfully.Considering a possible transfixing tip of the catheter and the patient's pain, a multidisciplinary decision of surgical extraction was considered.Atrial overdrive was performed, followed by the removal of all catheters and sheaths.The basket catheter was cut-off to the skin and the tip of the catheter was left abandoned.Surgical removal was performed 24 hours later by hemisection of the common femoral vein through a direct anterior approach.After thrombectomy, the catheter tip was extracted using a non-boston scientific ring dissector, with a remnant of an iliac valve found between 2 splines of the basket catheter.Patient was discharged 24 hours after surgery.At 3-months, vascular ultrasound found an asymptomatic refluxing proximal segment of the right internal iliac vein during valsalva manoeuvre, and no evidence of deep venous thrombosis.Ollitrault, p., champ-rigot, l., ferchaud, v., pellissier, a., coffin, o., & milliez, p.(2020).Vascular entrapment of a multipolar basket catheter (orion) during catheter ablation.Journal of cardiovascular electrophysiology.Doi:10.1111/jce.14780.
 
Manufacturer Narrative
It was indicated that the device will not be returned for evaluation.If there is any further relevant information obtained, a supplemental medwatch will be filed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INTELLAMAP ORION HIGH RESOLUTION MAPPING CATHETER
Type of Device
CATHETER, ELECTRODE RECORDING, OR PROBE, ELECTRODE RECORDING
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
MDR Report Key10489618
MDR Text Key205539822
Report Number2134265-2020-12282
Device Sequence Number1
Product Code DRF
UDI-Device Identifier08714729841968
UDI-Public08714729841968
Combination Product (y/n)N
PMA/PMN Number
K143481
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 10/21/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/28/2021
Device Model Number87035
Device Catalogue Number87035
Device Lot Number0024354629
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 08/20/2020
Initial Date FDA Received09/03/2020
Supplement Dates Manufacturer Received10/20/2020
Supplement Dates FDA Received10/21/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age65 YR
-
-